MADISON, Wis., May 6, 2025 /PRNewswire/ — The Food and Drug Administration Agency (FDA) has updated the regulatory status of Marie®, Leo Cancer Care’s upright particle therapy solution, to pending. Marie combines Leo Cancer Care’s upright patient positioning system with their upright fan beam CT scanner and can be utilized with any fixed particle beam.

Yale researchers have built a 3D-bioprinted synthetic aorta that they have successfully implanted into rats. This technology could advance the treatment of cardiovascular diseases such as coronary artery disease or peripheral arterial disease by allowing scientists to engineer and replace blood vessels in humans.

AliveCor announced today that it launched its most advanced personal ECG system, the AI-powered KardiaMobile 6L Max.

People who are given a vaccine for shingles have a 23% lower risk of cardiovascular events, including stroke, heart failure, and coronary heart disease, according to a study of more than a million people published in the European Heart Journal.

GE HealthCare (Nasdaq: GEHC) announced today that it received FDA 510(k) clearance for its Aurora nuclear medicine system and Clarify DL

A new probiotic could soon tackle the burden of heavy-metal-contaminated fish.

After spending years tracing the origin and migration pattern of an unusual type of immune cell in mice, researchers have shown in a new study how activity of “good” microbes in the gut is linked to rheumatoid arthritis and, potentially, other autoimmune diseases.

University of California, Davis researchers have developed a brain-computer interface (BCI) that enables computer cursor control and clicking, using neural signals from the speech motor cortex. One participant with amyotrophic lateral sclerosis (ALS) used the interface for daily life activities, including independent control of a personal desktop computer and text entry.